Holen Sie sich die Stockscreener-App
28.56
1.22%
-0.33
Schlusskurs vom Vortag:
$28.89
Offen:
$29.01
24-Stunden-Volumen:
3,466
Relative Volume:
0.09
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.42%
1M Leistung:
+26.61%
6M Leistung:
+63.55%
1J Leistung:
+21.96%
1-Tages-Spanne:
$28.77
$29.06
1-Wochen-Bereich:
$27.27
$29.11
52-Wochen-Spanne:
$13.96
$43.94
Amplify Seymour Cannabis Etf Stock (CNBS) Company Profile
Firmenname
Amplify Seymour Cannabis Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CNBS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNBS
Amplify Seymour Cannabis Etf
|
28.77 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
341.22 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
691.61 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
694.65 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
270.83 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
622.72 | 124.43B | 0 | 0 | 0 | 0.00 |
Amplify Seymour Cannabis Etf Aktie (CNBS) Neueste Nachrichten
Why Amplify Seymour Cannabis ETF stock remains top ratedEarnings Recap Report & Reliable Entry Point Alerts - ulpravda.ru
How Amplify Seymour Cannabis ETF stock compares with market leadersWeekly Investment Report & Smart Investment Allocation Insights - ulpravda.ru
How Amplify Seymour Cannabis ETF stock moves in volatile trading sessionsInsider Trading Compliance & Low Cost Wealth Building - ulpravda.ru
The Marijuana ETFs with Positive Returns in January 2026 - NerdWallet
Use this 2025 tax-saving strategy before the end of the year - AOL.com
Why Green Thumb Industries Stock Trounced the Market on Tuesday - AOL.com
Trump loosens medical marijuana rules, California billionaires eye leaving the state - AOL.com
After A Surprise Win In 2025, What Will 2026 Bring For The Amplify Cannabis ETF? | CNBS - Yahoo Finance
How Long Will the Cannabis Stock Rally Last? - AOL.com
Do These 2 Cannabis Stocks Have a Future? - AOL.com
This Stock Has Almost Tripled in 6 Months. Here's What Investors Need to Watch Next - AOL.com
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million? - AOL.com
Trump's Marijuana Reclassification Looks Set To Send This Cannabis ETF Soaring: Big Surge In Momentum - AOL.com
Down 99% in 5 Years, Is It Finally Time to Buy This Stock? - AOL.com
Why Amplify Seymour Cannabis ETF stock stays on buy listsJuly 2025 PreEarnings & Risk Controlled Swing Alerts - Улправда
Cloud lifts over cannabis companies' future amid push to reclassify the drug - MSN
Cannabis ETF (CNBS) Hits New 52-Week High - sharewise.com
CNBS: New Buy Rating On Cannabis ETF, Stoked By Positive Regulatory Trend (NYSEARCA:CNBS) - Seeking Alpha
Cannabis stocks selling off as Trump signs rescheduling order - Seeking Alpha
How Amplify Seymour Cannabis ETF stock behaves under inflation pressure2025 Fundamental Recap & Intraday High Probability Setup Alerts - Улправда
6 Top-Performing ETF Areas of Last Week - sharewise.com
Trump Says He’s ‘Strongly’ Considering Reclassifying Pot Via Executive Order - The Wealth Advisor
5 Best-Performing Leveraged ETFs of Last Week - sharewise.com
Trump says he's 'strongly' considering reclassifying pot via executive order - CNBC
Cannabis ETFs Soar Double-Digits on Friday: Here's Why - sharewise.com
Cannabis stocks roll higher as investors bet on Trump policy pivot - Wealth Professional Canada
Marijuana Stocks Jump as White House Moves to Reclassify Drug - NAI500
A Potential Policy Shift Ignites a Cannabis Stock Surge - AD HOC NEWS
Trump Expected to Reclassify Marijuana Monday, Sending Cannabis Stocks Soaring - Wall Street Pit
Cannabis stocks post record weekly gains on rescheduling hopes - MSN
Cannabis stocks rally on rescheduling hopes (MSOS:NYSEARCA) - Seeking Alpha
Trump Plans To Reclassify Marijuana, Driving Cannabis Stocks Higher - Arise News
Trump may significantly ease marijuana restrictions, causing cannabis stocks to soar. - 富途牛牛
🚨🇺🇸 BREAKING: TRUMP TO SIGN MARIJUANA RECLASSIFICATION ORDER AS SOON AS MONDAY, CANNABIS STOCKS EXPLODE The market is pricing in a new era. Trump is expected to sign an executive order as soon as Monday directing federal ag - x.com
Cannabis rescheduling fuels talk of an insurance boom - Insurance Business
5 ETFs to Watch as Restrictions on Marijuana Set to Ease - ETF Trends
Cannabis ETFs Eye A Breakout As Trump Weighs Major Marijuana Reclassification - Benzinga
'This time feels different': One cannabis investment insider thinks the industry will keep rallying following the latest reports of regulatory changes - CNBC
Trump’s Executive Order on cannabis rescheduling expected on Monday: CNBC - Seeking Alpha
Stock Market Live December 12: Trump to Ease Marijuana Regulation, S&P 500 (VOO) Flat - AOL.com
Marijuana Stocks Surge Amid Reports of Federal Regulation Easing - GuruFocus
Trump Reportedly Moving Marijuana to Schedule IIICannabis Stocks Rip, Tilray (TLRY) Soars 39% - Wall Street Pit
MJ: A Volatile Bet On The Cannabis Industry (MJ) - Seeking Alpha
This Stock-Split Stock Is Up 90% in the Past 6 Months: Is There More Upside Ahead? - AOL.com
Why analysts raise outlook for Amplify Seymour Cannabis ETF stockEntry Point & Free Community Consensus Stock Picks - Newser
Will Amplify Seymour Cannabis ETF stock announce a stock split2025 Buyback Activity & Precise Buy Zone Tips - Newser
Why Investors Were Buzzing About Curaleaf Stock Today - AOL.com
How Amplify Seymour Cannabis ETF stock performs in easing cyclesJuly 2025 Volume & Growth Focused Stock Reports - Newser
Will Amplify Seymour Cannabis ETF stock gain from lower interest ratesQuarterly Investment Review & Precise Buy Zone Identification - Newser
Is Amplify Seymour Cannabis ETF stock undervalued at current priceMarket Performance Recap & Reliable Price Breakout Alerts - Newser
How cyclical is Amplify Seymour Cannabis ETF stock compared to rivals2025 Analyst Calls & Entry Point Strategy Guides - Newser
Finanzdaten der Amplify Seymour Cannabis Etf-Aktie (CNBS)
Es liegen keine Finanzdaten für Amplify Seymour Cannabis Etf (CNBS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.37%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):